1 |
The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: an update review |
|
| | Jiaqi Zhai, Zijian Li, Yue Zhou, Xiuhua Yang | | | Journal of Reproductive Immunology. 2022; : 103490 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Predictive value of the s
econd-trimester
fibronectin concentration for severe preeclampsia: A prospective nested case–control study in China
|
|
| | Wei Li, Xiaowen Lin, Yuchen Chen, Kun Liu, Weibin Yang, Sifan Zeng, Jing Zhang | | | Journal of Obstetrics and Gynaecology Research. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis |
|
| | Kasiye Shiferaw Gemechu, Nega Assefa, Bizatu Mengistie | | | Women's Health. 2020; 16: 1745506520 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia |
|
| | Flávia Campos Lucena,Eura Martins Lage,Patrícia Gonçalves Teixeira,Alexandre Simões Barbosa,Rejane Diniz,Bashir Lwaleed,André Talvani,Patrícia Nessralla Alpoim,Luiza Oliveira Perucci,Luci Maria SantAna Dusse | | | Hypertension in Pregnancy. 2019; 38(1): 58 | | | [Pubmed] [Google Scholar] [DOI] | |
|